Molecular epidemiological and clinical infection characteristics analysis of Ralstonia

Zhaojun Sheng, Jiaxin Li, Guojing Han, Rui Fan, Pingjun Zhu, Xiangqun FangEuropean 2024 · DOI

This research paper, published in the European Journal of Clinical Microbiology & Infectious Diseases (2024), investigates the opportunistic pathogen Ralstonia pickettii. The study focuses on improving diagnostic accuracy, establishing a new molecular tracking system, and characterizing the clinical impact on patients.

TL;DR

Researchers have developed a high-resolution Multilocus Sequence Typing (MLST) system and a specific PCR assay to better identify and track Ralstonia pickettii, an emerging hospital-acquired pathogen. Their analysis reveals that while standard biochemical tests often misidentify the bacteria, molecular methods pinpoint "ST9" as a dominant, persistent clinical strain associated with severe respiratory symptoms in elderly patients.

What Problem Does This Paper Address?

Ralstonia pickettii is a Gram-negative bacillus increasingly recognized as a cause of nosocomial (hospital-acquired) outbreaks, often linked to contaminated medical solutions. However, it poses two major challenges for clinicians:

  1. Misidentification: It is phenotypically similar to the Burkholderia cepacia complex, leading to frequent misidentification by standard laboratory biochemical kits (like VITEK 2).
  2. Tracking Difficulty: There has been a lack of a standardized, high-resolution molecular "fingerprinting" system (MLST) to trace the origin of infections and understand how different strains spread within a hospital environment.

Methods

The researchers analyzed 48 strains collected over five years at the Chinese PLA General Hospital. Their approach combined traditional and novel techniques:

  • Identification Comparison: They compared the accuracy of the VITEK 2 system (biochemical) against specific PCR and 16S rDNA sequencing (the gold standard for bacterial identity).
  • Novel MLST System: The authors designed a new sequence typing system based on six conserved housekeeping genes (atpD, gltB, gyrB, lepA, phaC, and recA). This allows researchers to categorize bacteria into "Sequence Types" (STs) for epidemiological tracking.
  • Clinical & Susceptibility Testing: They performed a retrospective review of 30 patient records and conducted antibiotic sensitivity testing using both disc diffusion and broth microdilution methods.

Datasets

  • Bacterial Strains: 48 non-repetitive Ralstonia pickettii strains isolated from patients between January 2008 and December 2013 at the Chinese PLA General Hospital (PLAGH).
  • Clinical Data: Medical records from 30 infected patients, focusing on symptoms, underlying diseases, and treatment outcomes.

Key Insights and Ideas

  • The Specificity Gap: While the automated VITEK 2 system had 100% sensitivity, its specificity was only 70.8%. It frequently flagged other species (like R. insidiosa or Stenotrophomonas maltophilia) as R. pickettii. This highlights a critical need for molecular confirmation in clinical settings.
  • The "Two-Stage" Proposal: The authors advocate for a two-stage identification process: using 16S rDNA to confirm the species, followed by their new MLST system to achieve high-resolution strain differentiation.
  • Endemic Persistence: The discovery of ST9 as the "advantage type" (representing 22 of the 42 typed strains) is significant. This specific strain caused infections every year of the study, suggesting it is highly adapted to the hospital environment or a persistent source of contamination.
  • Vulnerable Populations: The infection predominantly affected the "oldest old"—the average patient age was 88, with many having underlying chronic lung or heart disease.

Key Results

  • Molecular Typing: The MLST system identified 18 distinct sequence types. ST9 was the most common, followed by ST2 and ST4.
  • Diagnostic Accuracy: The specific PCR assay showed 85.3% sensitivity and 85.7% specificity for R. pickettii, proving much more reliable than biochemical methods for species-level distinction.
  • Antibiotic Resistance: The bacteria showed high resistance to Aztreonam and Meropenem (100% resistance in disc diffusion tests). However, they remained sensitive to Cefoperazone/sulbactam, Cefepime, and Levofloxacin.
  • Clinical Presentation: 100% of patients presented with cough and sputum, 96.7% had pulmonary rales, and 93.3% experienced shortness of breath. The 30-day mortality rate was 13.3%.

Limitations and Future Work

  • Single-Center Study: The data comes from one hospital in Beijing, which may limit the generalizability of the antibiotic resistance patterns to other regions or countries.
  • Retrospective Nature: Because clinical data was collected retrospectively, some nuanced patient symptoms may have been missed.
  • Resolution Limits: While the 6-gene MLST is a major step forward, the authors note that adding more gene loci could provide even finer resolution for future outbreak investigations.
  • Sample Size: The study focused on a relatively small cohort (30 patients); larger multi-center studies are needed to confirm these clinical trends.

Summary updated

Abstract

We established a sequence typing system with a relatively fine resolution and the PCR assay is a faster and more sensitive method for clinical identification of Ralstonia pickettii. ST9 is the most common sequence types of Ralstonia pickettii. The most common clinical characteristics of Ralstonia pickettii infected patients were cough, sputum, shortness of breath and pulmonary rales.
BibTeX
@inproceedings{sheng2024molecular,
  author = {Zhaojun Sheng and Jiaxin Li and Guojing Han and Rui Fan and Pingjun Zhu and Xiangqun Fang},
  title = {{Molecular epidemiological and clinical infection characteristics analysis of Ralstonia}},
  booktitle = {European},
  year = {2024},
  doi = {10.1007/s10096-024-04823-w},
}
Figure